Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · Maryland

Cangene bioPharma, LLC

Baltimore, MD · ~294 workers · 4 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
1.2
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Cangene bioPharma, LLC runs at 35% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.

Cangene bioPharma, LLC: 1.2 TCR = 35% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

Cangene bioPharma, LLC safety composite

Cangene bioPharma, LLC scores strongest on total case rate (tcr) (safer than 64% of same-industry peers) and weakest on dart rate (safer than 42%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

53/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
C 1.16 per 100 workers

Safer than 64% of industry peers

DART rate
D 1 per 100 workers

Safer than 42% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Cangene bioPharma, LLC held a steady TCR band

Cangene bioPharma, LLC's TCR held near 0.1 from 1.3 in 2019 to 1.3 in 2022. Peak filing year was 2021 at 1.7 TCR. In 2022, DART was 0.86× this establishment's average TCR (severity share of cases).

2019=1.3 · 2020=0.3 · 2021=1.7 · 2022=1.3

OSHA ITA Form 300A scorecard

Establishment book 325412 · Baltimore, MD AT/BELOW-IND · MID

Grade A · TCR 1.2 · 35% of ind

  • DART 1.0 DART
  • RANK #7/12
  • PHOTO Woodstock Sterile So…
  • BOOK 4y book
  • INJ 14 inj
  • SIZE ~294 FTE

Nearest TCR peer: Woodstock Sterile Solutions (0.0 TCR gap)

Read with this employer → · Industry book → · Maryland employers → · Look up another →

Cangene bioPharma, LLC in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Cangene bioPharma, LLC averages 1.2 TCR (35% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Cangene bioPharma, LLC TCR series: 2019=1.3 · 2020=0.3 · 2021=1.7 · 2022=1.3 · BLS 3.3

Where Cangene bioPharma, LLC falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 64% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to Maryland alone (the establishments it most directly competes with for workers and contracts): ranked #7 safest of 12 Pharmaceutical preparations (e employers in Maryland.

Cangene bioPharma, LLC (294 employees, TCR 1.2) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Cangene bioPharma, LLC
Cangene bioPharma, LLC (294 employees, TCR 1.2) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Cangene bioPharma, LLC has more employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2022 1.3 1.0 5 0 0
2021 1.7 1.7 5 0 0
2020 0.3 0.3 1 0 0
2019 1.3 0.9 3 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · MD · Baltimore

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 7,213 rated employers in Maryland with headcount on file · 1,031 employers in Baltimore, MD · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Woodstock Sterile Solutions 1.2 TCR
NAICS-TCR Main office 1.2 TCR
NAICS-TCR Gilead Sciences, Inc. 1.2 TCR
NAICS-TCR Lilly Branchburg 1.1 TCR
STATE-SIZE 5382 294 FTE
STATE-SIZE Hagerstown MD FXFE-HGR 294 FTE
STATE-SIZE Buckhead Meat Mid-Atlantic 295 FTE
STATE-SIZE 8029 Corporate Drive 293 FTE
CITY-NEAR Johns Hopkins Hospital 12,523 FTE
CITY-NEAR University of Maryland Medical Center 7,980 FTE
CITY-NEAR Sinai Hospital of Baltimore 7,770 FTE
CITY-NEAR NGMS-T340 6,180 FTE
NAT-TCR Pishny Restoration Services 1.2 TCR
NAT-TCR Ridley Block Operations 1.2 TCR
NAT-TCR Comeback Rentals 1.2 TCR
NAT-TCR Welch Packaging Columbus 1.2 TCR
NAT-SIZE SIE - Santa Monica Studios 294 FTE
NAT-SIZE Accuride 294 FTE
NAT-SIZE Core-Mark Albuquerque 294 FTE
NAT-SIZE Modern Disposal Model City 294 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2022, 2021, 2020, 2019. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.